FDA Accepts COVID-19 Clinical Study and Advises on Next Steps for Pre-IND Filing by Medolife Rx

June 23, 2021

Lexaria’s Technology Lowers Blood Glucose More Effectively than Rybelsus-Branded GLP-1 drug Semaglutide Alone in Human Pilot Study

November 28, 2023
Lexaria’s Technology Improves the Oral Performance of the Rybelsus-Branded GLP-1 drug Semaglutide in Human Pilot Study

November 27, 2023
Blue Star Foods Provides Shareholder Update

November 27, 2023
Bit Origin Ltd Announces New Financing and Provides Business Plan Update

November 22, 2023